CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Studies show that levels of mitochondria-mediated oxidative phosphorylation (OXPHOS) are greater in CD34+ CML cells, and that mitochondrial metabolic activity in primitive CML cells is higher than in normal undifferentiated hematopoietic cells [5,6].